Description

BSE announces the listing of 7,240,000 equity shares of Accretion Nutraveda Limited with various lock-in periods ranging from May 2026 to February 2029.

Summary

BSE has listed 7,240,000 equity shares of Accretion Nutraveda Limited in dematerialized form. The shares have varying lock-in periods with the majority (1,376,000 shares) being freely tradable, while others are locked in until dates ranging from March 2026 to February 2029. All securities are fully paid equity shares held in demat form.

Key Points

  • Total securities listed: 7,240,000 equity shares
  • All securities are fully paid and in dematerialized form
  • Seven tranches with different distinctive number ranges
  • Lock-in periods vary: 272,000 shares until May 2026, 272,000 until March 2026, 1,448,000 until February 2028, 1,736,000 until February 2027, 400,000 until February 2027, 1,736,000 until February 2029
  • 1,376,000 shares are free from lock-in restrictions
  • Circular signed by Mayur Popatlal Sojitra, Managing Director

Regulatory Changes

No regulatory changes introduced. This is a standard listing notification.

Compliance Requirements

  • Shareholders must comply with lock-in restrictions for respective tranches
  • Locked-in shares cannot be traded until their respective lock-in expiry dates
  • All shares must remain in dematerialized form

Important Dates

  • March 3, 2026: Lock-in expiry for 272,000 shares (distinctive nos. 53,20,001 to 55,92,000)
  • May 2, 2026: Lock-in expiry for 272,000 shares (distinctive nos. 55,92,001 to 58,64,000)
  • February 2, 2027: Lock-in expiry for 2,136,000 shares (distinctive nos. 1 to 17,36,000 and 17,36,001 to 21,36,000)
  • February 2, 2028: Lock-in expiry for 1,448,000 shares (distinctive nos. 21,36,001 to 38,72,000)
  • February 2, 2029: Lock-in expiry for 1,736,000 shares (distinctive nos. 38,72,001 to 53,20,000)

Impact Assessment

Market Impact: Limited impact as this affects only Accretion Nutraveda Limited shareholders. The staggered lock-in release schedule may provide gradual liquidity over the next three years.

Liquidity: Immediate tradable float of 1,376,000 shares (19% of listed securities), with additional tranches becoming tradable progressively through 2029.

Investor Impact: Shareholders holding locked-in securities must wait until respective expiry dates before trading. The staggered unlock schedule may prevent sudden supply shocks to the stock price.

Impact Justification

Routine listing announcement for a single company with standard lock-in arrangements, affecting only specific shareholders of Accretion Nutraveda Limited